Jason Parker Brown serves as Executive at Karuna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jason Parker Brown has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 18, 2024 involved selling 14,009 shares valued at $4.6M.
Jason Parker Brown currently holds 7,158 shares of Karuna Therapeutics, Inc. (KRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Parker Brown has been a net neutral trader of KRTX stock. They have purchased $0 and sold $0 worth of shares.
Jason Parker Brown's most recent insider trade was on Mar 18, 2024, when they sold 14,009 shares at $330.00 per share.
Get notified when new Form 4 filings are submitted
| 7,158 |
| $330.00 |
| Discretionary |
| Feb 13, 2024 | KRTX | $88.4K | Payment | 278 | $318.00 | Discretionary |
| Sep 29, 2023 | KRTX | $0 | Award | 4,496 | $N/A | Discretionary |